Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Cancer Epidemiology
|
October 11, 2019
Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults
Olatunji B Alese, Renjian Jiang, Katerina M Zakka, et al.
JOP : Journal of the Pancreas
|
March 9, 2010
Management of skin toxicities of anti-EGFR agents in patients with pancreatic cancer and other GI tumors by using electronic communication: effective and convenient
Muhammad Wasif Saif, Kristin Kaley, Lynne Lamb, et al.
Pancreas
|
March 6, 2020
Young Adults With Pancreatic Cancer: National Trends in Treatment and Outcomes
Olatunji B Alese, Renjian Jiang, Walid Shaib, et al.
World Journal of Oncology
|
October 7, 2017
Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States
Olatunji B Alese, Sungjin Kim, Zhengjia Chen, et al.
Oncology
|
January 25, 2022
Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
Mohammed B Allaw, Jeffrey M Switchenko, Lana Khalil, et al.
Clinical Colorectal Cancer
|
March 20, 2021
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review
Evan Bryson, Elizabeth Sakach, Urvi Patel, et al.
Cancer Research and Treatment
|
June 6, 2015
Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome
Walid Shaib, Kavya Krishna, Sungjin Kim, et al.
Cancer Immunology, Immunotherapy : CII
|
June 23, 2021
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
Cameron J Herting, Matthew R Farren, Yan Tong, et al.
JCI Insight
|
December 13, 2019
Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemotherapy and radiotherapy
Matthew R Farren, Layal Sayegh, Michael Brandon Ware, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 15, 2016
Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas
Yue Xue, Alessandro Vanoli, Serdar Balci, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Cancer Epidemiology
|
October 11, 2019
Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults
Olatunji B Alese, Renjian Jiang, Katerina M Zakka, et al.
JOP : Journal of the Pancreas
|
March 9, 2010
Management of skin toxicities of anti-EGFR agents in patients with pancreatic cancer and other GI tumors by using electronic communication: effective and convenient
Muhammad Wasif Saif, Kristin Kaley, Lynne Lamb, et al.
Pancreas
|
March 6, 2020
Young Adults With Pancreatic Cancer: National Trends in Treatment and Outcomes
Olatunji B Alese, Renjian Jiang, Walid Shaib, et al.
World Journal of Oncology
|
October 7, 2017
Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States
Olatunji B Alese, Sungjin Kim, Zhengjia Chen, et al.
Oncology
|
January 25, 2022
Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
Mohammed B Allaw, Jeffrey M Switchenko, Lana Khalil, et al.
Clinical Colorectal Cancer
|
March 20, 2021
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review
Evan Bryson, Elizabeth Sakach, Urvi Patel, et al.
Cancer Research and Treatment
|
June 6, 2015
Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome
Walid Shaib, Kavya Krishna, Sungjin Kim, et al.
Cancer Immunology, Immunotherapy : CII
|
June 23, 2021
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
Cameron J Herting, Matthew R Farren, Yan Tong, et al.
JCI Insight
|
December 13, 2019
Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemotherapy and radiotherapy
Matthew R Farren, Layal Sayegh, Michael Brandon Ware, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 15, 2016
Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas
Yue Xue, Alessandro Vanoli, Serdar Balci, et al.
Page
of 4